Carbios SASBioplasticsCarbios SAS to expand PET recycling portfo...French bioplastics recycling specialist Carbios SAS and British recycling and waste management company FCC Environment want to establish a PET biorecycling facility in the UK. more ➔
Adaütimmune LtdcancerFDA approves cell therapy for solid tumour...The US Food & Drug Administration has granted accelerated approval to Adaptimmune’s Tecelra as the world’s first therapy with genetically engineered T cells to fight a solid tumour. more ➔
Armed Forces Institute of Pathology, AFIPvaccinesValneva licences LimmaTech’s Shigella va...French-Austrian vaccine maker Valneva SE has secured exclusive worldwide rights to commercialise LimmaTech Biologics AG’s S4V Shigella vaccine that will be tested in two Phase II trials starting in … more ➔
SIATfinancingBI Venture Funds invests in oncolytic bact...With an investment of its venture arm (BI-VF), Boehringer Ingelheim underlines its committment to expand the reach of cancer immune therapies. The Series A financing in Chinese Synthetica Pioneering … more ➔
Maxwell Hamilton - wikipedia.orgpartnershipGSK and Flagship Pioneering ink US$7.2bn b...As one of the last Big Pharma companies, GlaxoSmithKline plc has inked a drug discovery licence option deal for up to 10 programmes with US-based biotech platform company supplier Flagship Pioneering … more ➔
Romain BuissonNovel FoodGourmey files first EU application for cel...Not the German InFamily Foods subsidiary The Cultivated B, but Gourmey SAS, founded in Paris in 2019 by Antoine Davydoff, Nicolas Morin-Forest and Victor Sayous, has submitted the first EU authorisation … more ➔
Confo Therapeutics NVfinancingConfo Therapeutics closes €60m Series B...Belgian GPCR specialist Confo Therapeutics NV has raised €60m in an Series B financing round led by Ackermans & van Haaren to advance clinical development of two clinical programmes and preclinical … more ➔
AC Immune SAAlzheimer’s DiseaseAC Immune bags FDA fast track designationSwiss AC Immune and its partner Janssen Pharmaceuticals Inc have been granted FDA Fast Track Designation for their active anti-pTau vaccine ACI-35.030/JNJ-2056 to treat Alzheimer’s disease. more ➔
Jan Kroenke, Charité BerlinMultiple myeloma New targets for incurable blood cancerA research consortium led by Charité in Berlin has found a protein pattern in 100 patients with the common blood cancer multiple myeloma and 38 healthy controls that independently identifies a poor … more ➔
Evotec SEgene therapySynaptixBio Ltd and Evotec SE expand colla...Evotec SE is widening its 2022 R&D collaboration SynaptixBio Ltdi to optimise and identify new antisense oligonucleotides to treat children with H-ABC leukodystrophy, a rare genetic myelin synthesis … more ➔
Carbios SAS
Adaütimmune Ltd
Armed Forces Institute of Pathology, AFIP
SIAT
Maxwell Hamilton - wikipedia.org
Romain Buisson
Confo Therapeutics NV
AC Immune SA
Jan Kroenke, Charité Berlin
Evotec SE